ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2154

Efficacy of an Intensive 24-Week Physiotherapy Programme in Patients with Idiopathic Inflammatory Myopathies – Preliminary Data from a Single-Center Controlled Study

Maja Spiritovic1,2, Sabina Oreska1, Hana Storkanova1, Petr Cesak2, Adela Rathouska1, Katerina Kubinova1, Martin Klein1, Lucia Vernerova1, Olga Ruzickova1, Herman F Mann1, Karel Pavelka1, Ladislav Senolt1, Jiri Vencovsky1 and Michal Tomcik1, 1Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, 2Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic, Prague, Czech Republic

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Idiopathic Inflammatory Myopathies (IIM), myopathy and physical therapy

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Muscle Biology, Myositis and Myopathies Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Involvement of musculoskeletal system (inflammation, atrophy and permanent damage to the muscle) in idiopathic inflammatory myopathies (IIM) leads to impaired function, reduced muscle strength, endurance and aerobic capacity, decreasing quality of life. Data on efficacy of non-pharmacologic care in IIM is very limited due to variety in studied interventions/outcomes. The aim of our study was to address the limitations of existing studies, and evaluate the effect of a controlled, long-term (24-week intervention, 24-week follow-up), intensive (1h physiotherapy twice weekly, and home-exercise for 1h 5x weekly), tailored physiotherapy program to improve muscle strength, endurance and deep stabilizer system, and quality of life/disability in cohorts with a substantial number of IIM patients.

Methods: All patients fulfilled the Bohan and Peter 1975 diagnostic criteria for dermatomyositis (DM) or polymyositis (PM), had skeletal muscle involvement, and were consecutively recruited from 2014 to 2016 at the Institute of Rheumatology in Prague. Both groups received educational materials and instructions for home exercise at baseline, however, only intervention group underwent the intensive physiotherapy programme. At months 0,3,6,12 all patients were assessed by a physician (physical examination, MITAX, MYOACT, and MDI), and a physiotherapist blinded to intervention (standardized tests evaluating the level of muscle strength MMT-8), and endurance (FI-2), patients filled out patient reported outcomes (PRO)/questionnaires [HAQ, SF-36, Beck’s depression inventory-II (BDI-II), PROs assessing nutrition and fatigue], body composition was analyzed using densitometry (iDXA Lunar) and bioelectric impedance (BIA2000-M), and patients provided blood for routine laboratory analysis and biobanking. Normality of data was tested and inter-group analysis performed with 2-way ANOVA and intra-group analysis by Friedman’s test with Dunn’s post hoc test.

Results: 27 IIM patients (22 female / 5 male, 10 DM / 12 PM / 5 IMNM (immune mediated necrotizing myopathy), median of age 58.0 and disease duration 7.0 years) were recruited into the intervention group (IG) and 27 patients into the control group (CG) (24 female / 3 male, 13 DM / 12 PM / 2 IMNM, median of age 56.5 and disease duration 4.7 years). Compared to observed statistically significant deterioration in CG over the period of months 0-6, we found statistically significant improvement in FI-2, MMT8, HAQ, BDI-II (Table 1). Only numerical improvement in IG compared to numerical deterioration in CG, which has not reached statistical significance, was observed in SF-36 and fatigue PROs.

Conclusion: Our intensive 24-week physiotherapy programme led to a significant improvement in muscle strength, endurance, function and depression, which was clinically meaningful in a substantial proportion of patients.

Acknowledgement: Supported by AZV-16-33574A.

Parameter

(unit)

Intervention group

Mean ± SEM

Control group

Mean ± SEM

Intra-group analysis (Friedman+Dunn)

Inter-group analysis (2WA)

Interevention gr.

Control group

MMT-8

m0: 54.7 ± 2.6

m0: 64.2 ± 2.3

m0-m3: p<0.001

m0-m3: p<0.01

p<0.0001

m3: 60.7 ± 2.4

m3: 58.4 ± 2.0

m3-m6: p<0.01

m3-m6: p=NS

m6: 69.1 ± 1.9

m6: 55.3 ± 2.0

m0-m6: p<0.001

m0-m6: p<0.001

FI-2 (%)

m0: 30.0 ± 4.4

m0: 40.2 ± 5.9

m0-m3: p<0.001

m0-m3: p=NS

p<0.0001

m3: 46.9 ± 4.7

m3: 30.8 ± 4.9

m3-m6: p<0.001

m3-m6: p=NS

m6: 70.6 ± 4.9

m6: 28.7 ± 4.5

m0-m6: p<0.001

m0-m6: p<0.01

HAQ

m0: 0.91 ± 0.16

m0: 1.25 ± 0.17

m0-m3: p=NS

m0-m3: p=NS

p=0.0012

m3: 0.69 ± 0.14

m3: 1.33 ± 0.18

m3-m6: p=NS

m3-m6: p=NS

m6: 0.56 ± 0.11

m6: 1.27 ± 0.19

m0-m6: p<0.001

m0-m6: p=NS

BDI-II

m0: 11.9 ± 2.1

m0: 13.3 ± 1.5

m0-m3: p=NS

m0-m3: p=NS

p=0.0186

m3: 10.7 ± 1.7

m3: 15.2 ± 1.8

m3-m6: p=NS

m3-m6: p=NS

m6: 8.9 ± 1.5

m6: 14.6 ± 1.4

m0-m6: p<0.05

m0-m6: p=NS

Acronyms: SEM, standard error of the mean; Friedman, Friedman’s test; Dunn, Dunn’s post hoc test; 2WA, two way ANOVA, MMT-8, Manual muscle test-8; FI-2, Functional index-2; HAQ, Health assessment questionnaire`BDI-II, Beck’s depression inventory-II; m0, month 0 (= at the baseline); m3, month 3 (= in the middle of intervention period); m6, month 6 (= at the end of intervention); p, p-value; NS, not significant


Disclosure: M. Spiritovic, None; S. Oreska, None; H. Storkanova, None; P. Cesak, None; A. Rathouska, None; K. Kubinova, None; M. Klein, None; L. Vernerova, None; O. Ruzickova, None; H. F. Mann, None; K. Pavelka, None; L. Senolt, None; J. Vencovsky, Samsung Bioepis Co., Ltd., Biogen, 5; M. Tomcik, None.

To cite this abstract in AMA style:

Spiritovic M, Oreska S, Storkanova H, Cesak P, Rathouska A, Kubinova K, Klein M, Vernerova L, Ruzickova O, Mann HF, Pavelka K, Senolt L, Vencovsky J, Tomcik M. Efficacy of an Intensive 24-Week Physiotherapy Programme in Patients with Idiopathic Inflammatory Myopathies – Preliminary Data from a Single-Center Controlled Study [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/efficacy-of-an-intensive-24-week-physiotherapy-programme-in-patients-with-idiopathic-inflammatory-myopathies-preliminary-data-from-a-single-center-controlled-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/efficacy-of-an-intensive-24-week-physiotherapy-programme-in-patients-with-idiopathic-inflammatory-myopathies-preliminary-data-from-a-single-center-controlled-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology